NCT05396807View on ClinicalTrials.gov

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

November 25, 2024

Conditions
Metastatic Colon Cancer
Interventions
DEVICE

AI

The aim of using AI software to support physicians in choosing the most effective treatment.

Trial Locations (6)

30202

Hospital General Universitario Santa Lucía, Cartagena

50121

Scienze della Salute Università degli Studi di Firenze, Florence

90127

Unità Oncologia Medica Dipartimento di Discipline Chirurgiche, Oncologiche e Stomatologiche, Palermo

700115

"Grigore T. Popa University of Medicine and Pharmacy of Iași", Iași

700483

Regional Institute of Oncology, Iași

00133

Medical Oncology Unit, Department of Oncohematology, Policlinico Tor Vergata, Roma

All Listed Sponsors
lead

University of Rome Tor Vergata

OTHER